Matthew W Foehr Viking Therapeutics, Inc. (VKTX) insider trading activity

VKTX Quotes by TradingView

Matthew W Foehr is Director of Viking Therapeutics, Inc.. Currently has a direct ownership of 111,250 shares of VKTX, which is worth approximately $7.17 Million. The most recent transaction as insider was on May 02, 2022, when has been sold 45,000 shares (Common stock, par value $0.00001 per share) at a price of $2.47 per share, resulting in proceeds of $111,150. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 111K
0% 3M change
0% 12M change
Total Value Held $7.17 Million

MATTHEW W FOEHR Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 02 2022
BUY
Open market or private purchase
$111,150 $2.47 p/Share
45,000 Added 28.8%
111,250 Common stock, par valu...
Jun 10 2021
BUY
Open market or private purchase
$113,800 $5.69 p/Share
20,000 Added 23.19%
66,250 Common stock, par valu...
Mar 22 2021
BUY
Exercise of in-the-money or at-the-money derivatives securities
$30,000 $1.5 p/Share
20,000 Added 30.19%
46,250 Common stock, par valu...

Also insider at

LGND
LIGAND PHARMACEUTICALS INC Healthcare
AHPAW
Avista Public Acquisition Corp. II Financial Services
President and CEO
MWF

Matthew W Foehr

Director
Emeryville, CA

Track Institutional and Insider Activities on VKTX

Follow Viking Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VKTX shares.

Notify only if

Insider Trading

Get notified when an Viking Therapeutics, Inc. insider buys or sells VKTX shares.

Notify only if

News

Receive news related to Viking Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VKTX